Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy.
Lima L, Severino PF, Silva M, Miranda A, Tavares A, Pereira S, Fernandes E, Cruz R, Amaro T, Reis CA, Dall'Olio F, Amado F, Videira PA, Santos L, Ferreira JA. Lima L, et al. Among authors: miranda a. Br J Cancer. 2013 Oct 15;109(8):2106-14. doi: 10.1038/bjc.2013.571. Epub 2013 Sep 24. Br J Cancer. 2013. PMID: 24064971 Free PMC article.
Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Gaiteiro C, Soares J, Relvas-Santos M, Peixoto A, Ferreira D, Paulo P, Brandão A, Fernandes E, Azevedo R, Palmeira C, Freitas R, Miranda A, Osório H, Prieto J, Lima L, Silva AMN, Santos LL, Ferreira JA. Gaiteiro C, et al. Among authors: miranda a. Theranostics. 2022 Mar 28;12(7):3150-3177. doi: 10.7150/thno.67409. eCollection 2022. Theranostics. 2022. PMID: 35547758 Free PMC article.
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy.
Freitas R, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Ferreira E, Gaiteiro C, Soares J, Cotton S, Gonçalves M, Eiras M, Santos B, Palmeira C, Correia MP, Oliveira MJ, Sarmento B, Peixoto A, Santos LL, Silva AMN, Ferreira JA. Freitas R, et al. Among authors: miranda a. J Control Release. 2024 Mar;367:540-556. doi: 10.1016/j.jconrel.2024.01.065. Epub 2024 Feb 3. J Control Release. 2024. PMID: 38301927
Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy.
Freitas R, Ferreira E, Miranda A, Ferreira D, Relvas-Santos M, Castro F, Santos B, Gonçalves M, Quintas S, Peixoto A, Palmeira C, Silva AMN, Santos LL, Oliveira MJ, Sarmento B, Ferreira JA. Freitas R, et al. Among authors: miranda a. ACS Nano. 2024 Apr 9;18(14):10088-10103. doi: 10.1021/acsnano.3c12487. Epub 2024 Mar 27. ACS Nano. 2024. PMID: 38535625
Examining variations in body composition among patients with colorectal cancer according to site and disease stage.
da Silva Nascimento ML, Alves Bennemann N, de Sousa IM, de Oliveira Bezerra MR, Villaça Chaves G, Moreira Lima Verde SM, Fernandes Maurício S, Barreto Campello Carvalheira J, Santos Mendes MC, Miranda AL, da Costa Pereira JP, Gonzalez MC, Prado CM, Fayh APT. da Silva Nascimento ML, et al. Among authors: miranda al. Sci Rep. 2024 May 11;14(1):10829. doi: 10.1038/s41598-024-61790-0. Sci Rep. 2024. PMID: 38734789
Disparities in cancer incidence by sexual orientation.
Huang AK, Hoatson T, Chakraborty P, McKetta S, Soled KRS, Reynolds CA, Boehmer U, Miranda AR, Streed CG Jr, Maingi S, Haneuse S, Young JG, Kang JH, Austin SB, Eliassen AH, Charlton BM. Huang AK, et al. Among authors: miranda ar. Cancer. 2024 May 11. doi: 10.1002/cncr.35356. Online ahead of print. Cancer. 2024. PMID: 38733613
2,111 results